Aura Biosciences
Healthcare & Life Sci
Company overview
Aura Biosciences is a clinical-stage biotechnology company based in Boston. It develops precision therapies for solid tumors using virus-like drug conjugates. Its lead candidate, belzupacap sarotalocan (bel-sar), is in development as a first-line treatment for early-stage choroidal melanoma and bladder cancer. Aura Biosciences is an H-1B sponsor.
- Industry
- Healthcare & Life Sci
- Headquarters
- Boston, United States